[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6128 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 6128

To require the Administrator of the Environmental Protection Agency to 
 conduct a study on the presence of pharmaceuticals and personal care 
                 products in sources of drinking water.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 22, 2016

Ms. Schakowsky introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To require the Administrator of the Environmental Protection Agency to 
 conduct a study on the presence of pharmaceuticals and personal care 
                 products in sources of drinking water.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Water, Cosmetics, and Unwanted 
Pharmaceuticals Study Act''.

SEC. 2. PRESENCE OF PHARMACEUTICALS AND PERSONAL CARE PRODUCTS IN 
              SOURCES OF DRINKING WATER.

    Subsection (a) of section 1442 of the Safe Drinking Water Act (42 
U.S.C. 300j-1) is amended by adding at the end the following:
    ``(11) Presence of Pharmaceuticals and Personal Care Products in 
Sources of Drinking Water.--
            ``(A) Study.--The Administrator shall carry out a study on 
        the presence of pharmaceuticals and personal care products in 
        sources of drinking water, which shall--
                    ``(i) identify pharmaceuticals and personal care 
                products that have been detected in sources of drinking 
                water and the levels at which such pharmaceuticals and 
                personal care products have been detected;
                    ``(ii) identify the sources of pharmaceuticals and 
                personal care products in sources of drinking water, 
                including point sources and nonpoint sources of 
                pharmaceutical and personal care products;
                    ``(iii) identify the effects of such 
                pharmaceuticals and personal care products on humans, 
                the environment, and the safety of drinking water; and
                    ``(iv) identify methods to control, limit, treat, 
                or prevent the presence of such pharmaceuticals and 
                personal care products.
            ``(B) Consultation.--The Administrator shall conduct the 
        study described in subparagraph (A) in consultation with the 
        Secretary of Health and Human Services (acting through the 
        Commissioner of Food and Drugs), the Director of the United 
        States Geological Survey, the heads of other appropriate 
        Federal agencies (including the National Institute of 
        Environmental Health Sciences), and other interested 
        stakeholders (including manufacturers of pharmaceuticals and 
        personal care products and consumer groups and advocates).
            ``(C) Report.--Not later than 4 years after the date of the 
        enactment of this paragraph, the Administrator shall submit to 
        the Congress a report on the results of the study carried out 
        under this paragraph.
            ``(D) Definitions.--In this paragraph:
                    ``(i) The term `personal care product' has the 
                meaning given the term `cosmetic' in section 201 of the 
                Federal Food, Drug, and Cosmetic Act.
                    ``(ii) The term `pharmaceutical' has the meaning 
                given the term `drug' in section 201 of the Federal 
                Food, Drug, and Cosmetic Act.''.
                                 <all>